Kommentierte Zusammenfassung der Leitlinien der European Society of Cardiology zur Infektiösen Endokarditis (Neuauflage 2009)
Tóm tắt
Từ khóa
Tài liệu tham khảo
Fowler VG Jr, Miro JM, Hoen B et al (2005) ICE Investigators. Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA 293:3012–3021
Murdoch DR, Corey GR, Hoen B et al (2009) International Collaboration on Endocarditis-Prospective Cohort Study (ICE-PCS) investigators. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med 169:463–473
Wilson W, Taubert KA, Gewitz M et al (2007) Prevention of infective endocarditis: guidelines from the American Heart Association. Circulation 116:1736–1754
Naber CK, Al-Nawas B, Baumgartner H et al (2007) Prophylaxe der Infektiösen Endokarditis. Kardiologe 4:243–252
Nishimura RA, Carabello BA, Faxon DP et al (2008) ACC/AHA 2008 Guideline update on valvular heart disease: focused update on infective endocarditis. J Am Coll Cardiol 52:676–685
Richey R, Wray D, Stokes T (2008) Guideline Development Group. Prophylaxis against infective endocarditis: summary of NICE guidance. BMJ 336:770–771
Habib G, Hoen B, Tornos P et al (2009) Guidelines on the prevention, diagnosis, and treatment of infective endocarditis. Eur Heart J 30:2369–2413
Horstkotte D, Follath F, Gutschik E et al (2004) Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary; the task force on infective endocarditis of the European Society of Cardiology. Eur Heart J 25:267–276
Roberts GJ, Simmons NB, Longhurst P, Hewitt PB (1998) Bacteraemia following local anaesthetic injections in children. Br Dent J 185:295–298
Daniel WG, Mügge A, Martin RP et al (1991) Improvement in the diagnosis of abscesses associated with endocarditis by transesophageal echocardiography. N Engl J Med 324:795–800
Kini V, Logani S, Ky B et al (2010) Transthoracic and transesophageal echocardiography for the indication of suspected infective endocarditis: vegetations, blood cultures and imaging. J Am Soc Echocardiogr (Epub ahead of print)
Naber CK, Erbel R (2007) Infective endocarditis with negative blood cultures. Int J Antimicrob Agents. 30:S32–S36
Fenollar F, Raoult D (2007) Molecular diagnosis of bloodstream infections caused by non-cultivable bacteria. Int J Antimicrob Agents 30(Suppl 1):S7–S15
Durack DT, Lukes AS, Bright DK (1994) New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Am J Med 96:200–209
Falagas ME, Matthaiou DK, Bliziotis IA (2006) The role of aminoglycosides in combination with a beta-lactam for the treatment of bacterial endocarditis: a meta-analysis of comparative trials. J Antimicrob Chemother 57:639–647
Paul M, Benuri-Silbiger I, Soares-Weiser K, Leibovici L (2004) Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials. BMJ 328:668
Cosgrove SE, Vigliani GA, Fowler VG Jr et al (2009) Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic. Clin Infect Dis 48:713–721
Fowler VG Jr, Boucher HW, Corey GR et al (2006) S. aureus Endocarditis and Bacteremia Study Group. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med 355:653–665
Stryjewski ME, Szczech LA, Benjamin DK Jr et al (2007) Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia. Clin Infect Dis 44:190–196
Kim SH, Kim KH, Kim HB et al (2008) Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia. Antimicrob Agents Chemother 52:192–197
Woodford N, Johnson AP, Morrison D, Speller DC (1995) Current perspectives on glycopeptide resistance. Clin Microbiol Rev 8:585–615
Soriano A, Marco F, Martínez JA et al (2008) Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis 46:193–200
Naber CK, Baddour LM, Giamarellos-Bourboulis EJ et al (2009) Clinical consensus conference: survey on Gram-positive bloodstream infections with a focus on Staphylococcus aureus. Clin Infect Dis 48(Suppl 4):S260–S270
Appelbaum PC (2007) Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA). Int J Antimicrob Agents 30:398–408
Bae IG, Federspiel JJ, Miró JM et al (2009) International collaboration on endocarditis-microbiology investigator. Heterogeneous vancomycin-intermediate susceptibility phenotype in bloodstream methicillin-resistant Staphylococcus aureus isolates from an international cohort of patients with infective endocarditis: prevalence, genotype, and clinical significance. J Infect Dis 200:1355–1366
Agarwal VK, McHutchison JG, Hoofnagle JH (2010) Drug-induced liver injury network.important elements for the diagnosis of drug-induced liver injury. Clin Gastroenterol Hepatol (Epub ahead of print)
Amodeo MR, Clulow T, Lainchbury J et al (2009) Outpatient intravenous treatment for infective endocarditis: safety, effectiveness and one-year outcomes. J Infect 59:387–393
Dickerman SA, Abrutyn E, Barsic B et al (2007) The relationship between the initiation of antimicrobial therapy and the incidence of stroke in infective endocarditis: an analysis from the ICE Prospective Cohort Study (ICE-PCS). Am Heart J 154:1086–1094
Wang A, Athan E, Pappas PA et al (2007) Contemporary clinical profile and outcome of prosthetic valve endocarditis. JAMA 297:1354–1361